文献速递主动脉疾病

血流介导舒张与腹主动脉瘤进展

Flow Mediated Dilatation and Progression of Abdominal Aortic Aneurysms.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-04-14

在162例腹主动脉瘤患者的前瞻性队列中,血流介导舒张(FMD)与动脉瘤直径及未来12个月进展呈负相关,FMD在监测期间恶化而手术修复后改善,提示FMD可能是AAA进展的潜在生物标志物。

要点

  • FMD在AAA监测期间恶化,手术修复后改善

核心结论

  • FMD与未来AAA进展呈负相关,在AAA自然病程中恶化,手术修复后改善。

研究设计与样本

  • 前瞻性招募的AAA患者队列(牛津腹主动脉瘤研究),共162例,超声测量AAA前后径,同期评估FMD。

主要发现

  • FMD与所有患者AAA直径呈负相关(n=162,Spearman's r=-.28,p<.001)。
  • FMD与未来12个月AAA直径进展呈负相关(Spearman's r=-.35,p=.001),尤其在中度大小组。
  • FMD在AAA监测期间恶化(中位数从基线2.0%降至随访1.2%;p=.004)。
  • 手术修复AAA(n=50,开放22例,腔内28例)后FMD改善(从术前1.1%至术后3.8%;p<.001),与手术类型无关。

临床怎么用

  • FMD作为无创内皮功能指标,可能用于AAA患者进展风险分层,但需进一步研究验证。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: Biomarker(s) for prediction of the future progression rate of abdominal aortic aneurysms (AAA) may be useful to stratify the management of individual patients. AAAs are associated with features of systemic inflammation and endothelial dysfunction. Flow mediated dilatation (FMD) of the brachial artery is a recognised non-invasive measurement for endothelial function. We hypothesised that FMD is a potential biomarker of AAA progression and reflects the temporal changes of endothelial function during AAA progression. METHODS: In a prospectively recruited cohort of patients with AAAs (Oxford Abdominal Aortic Aneurysm Study), AAA size was recorded by antero-posterior diameter (APD) (outer to outer) on ultrasound. Annual AAA progression was calculated by (ΔAPD/APD at baseline)/(number of days lapsed/365 days). FMD was assessed at the same time as AAA size measurement. Analyses of data were performed in the overall cohort, and further in subgroups of AAA by size (small: 30-39 mm; moderate: 40-55 mm; large: > 55 mm). RESULTS: FMD is inversely correlated with the diameter of AAAs in all patients (n=162, Spearman's r=-.28, p<.001). FMD is inversely correlated with AAA diameter progression in the future 12 months (Spearman's r=-.35, p=.001), particularly in the moderate size group. Furthermore, FMD deteriorates during the course of AAA surveillance (from a median of 2.0% at baseline to 1.2% at follow-up; p=.004), while surgical repair of AAAs (n=50 [open repair n=22, endovascular repair n=28)] leads to an improvement in FMD (from 1.1% pre-operatively to 3.8% post-operatively; p<.001), irrespective of the type of surgery. CONCLUSION: FMD is inversely correlated with future AAA progression in humans. FMD deteriorates during the natural history of AAA, and is improved by surgery. The utility of FMD as a potential biomarker in the context of AAA warrants further investigation.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Lee R, Bellamkonda K, Jones A, et al. Flow Mediated Dilatation and Progression of Abdominal Aortic Aneurysms. Eur J Vasc Endovasc Surg. 2017. PMID: 28416190. doi:10.1016/j.ejvs.2017.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。